Articles > Mouwasat Medical Services Co. Releases Strong Interim Financial Results for Q1 2026
Mouwasat Medical Services Co. Releases Strong Interim Financial Results for Q1 2026
By KlickAnalytics Data Insights | April 29, 2026 11:07AM ET
- Sales revenue increased by 9.1% to SAR 833.8 million compared to the same quarter last year
- Net profit attributable to shareholders rose by 2% to SAR 201 million from Q1 of the previous year
- Decrease in revenue by 5.7% compared to the previous quarter due to seasonal effects
Mouwasat Medical Services Co. recently disclosed its interim financial results for the period ending on March 31, 2026. The company reported a significant increase in sales revenue, reaching SAR 833.8 million, marking a 9.1% rise compared to the same quarter of the previous year. This growth was attributed to an increase in occupancy rates in inpatient departments, improved contractual terms with clients, and the commencement of operations at Al Mouwasat Hospital in Yanbu Industrial City in February 2026.
Furthermore, the net profit attributable to shareholders saw a 2% increase, totaling SAR 201 million for the current quarter. This growth was mainly driven by the flexible operating model's ability to handle profit margin pressures from strategic expansions, including the opening of the Yanbu Industrial City Hospital. Additionally, decreased provisions under Zakat expenses also positively impacted the net profit results.
However, the company experienced a 5.7% decrease in revenue compared to the previous quarter, mainly due to seasonal effects related to the holy month of Ramadan. This decline led to a decrease in outpatient visit volumes and subsequent revenue impact. As a result, the net profit for the current quarter decreased by 15.7% compared to the previous quarter, reflecting the challenging operational environment following the new hospital's operations in Yanbu Industrial City.
In conclusion, an unmodified conclusion was provided in the external auditor's report, acknowledging the company's strong performance. Mouwasat Medical Services Co. also highlighted the reclassification of certain comparative figures for better presentation and invited investors and financial analysts to direct inquiries via email within six working days after the financial statements' publication.
- Net profit attributable to shareholders rose by 2% to SAR 201 million from Q1 of the previous year
- Decrease in revenue by 5.7% compared to the previous quarter due to seasonal effects
Mouwasat Medical Services Co. recently disclosed its interim financial results for the period ending on March 31, 2026. The company reported a significant increase in sales revenue, reaching SAR 833.8 million, marking a 9.1% rise compared to the same quarter of the previous year. This growth was attributed to an increase in occupancy rates in inpatient departments, improved contractual terms with clients, and the commencement of operations at Al Mouwasat Hospital in Yanbu Industrial City in February 2026.
Furthermore, the net profit attributable to shareholders saw a 2% increase, totaling SAR 201 million for the current quarter. This growth was mainly driven by the flexible operating model's ability to handle profit margin pressures from strategic expansions, including the opening of the Yanbu Industrial City Hospital. Additionally, decreased provisions under Zakat expenses also positively impacted the net profit results.
However, the company experienced a 5.7% decrease in revenue compared to the previous quarter, mainly due to seasonal effects related to the holy month of Ramadan. This decline led to a decrease in outpatient visit volumes and subsequent revenue impact. As a result, the net profit for the current quarter decreased by 15.7% compared to the previous quarter, reflecting the challenging operational environment following the new hospital's operations in Yanbu Industrial City.
In conclusion, an unmodified conclusion was provided in the external auditor's report, acknowledging the company's strong performance. Mouwasat Medical Services Co. also highlighted the reclassification of certain comparative figures for better presentation and invited investors and financial analysts to direct inquiries via email within six working days after the financial statements' publication.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.